Brukinsa
Jump to navigation
Jump to search
| Brukinsa | |
|---|---|
| Term | Brukinsa |
| Short definition | Brukinsa - (pronounced) (BROO-kin-suh) A drug used to treat adults with certain types of non-Hodgkin's lymphoma, including mantle cell lymphoma, marginal zone lymphoma, and Waldenstrom's macroglobulinemia. It is also being studied in the treatment of other types of cancer. |
| Type | Cancer terms |
| Specialty | Oncology |
| Language | English |
| Source | NCI |
| Comments | |
Brukinsa - (pronounced) (BROO-kin-suh) A drug used to treat adults with certain types of non-Hodgkin's lymphoma, including mantle cell lymphoma, marginal zone lymphoma, and Waldenstrom's macroglobulinemia. It is also being studied in the treatment of other types of cancer. Brukinsa blocks a protein called BTK, which may help prevent cancer cells from growing. It's a type of tyrosine kinase inhibitor. Also called zanubrutinib
External links
- Medical encyclopedia article on Brukinsa
- Wikipedia's article - Brukinsa
This WikiMD dictionary article is a stub. You can help make it a full article.
Languages: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
Urdu,
বাংলা,
తెలుగు,
தமிழ்,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
European
español,
Deutsch,
français,
русский,
português do Brasil,
Italian,
polski